PL387217A1 - Borate derivatives of adenosine - Google Patents

Borate derivatives of adenosine

Info

Publication number
PL387217A1
PL387217A1 PL387217A PL38721709A PL387217A1 PL 387217 A1 PL387217 A1 PL 387217A1 PL 387217 A PL387217 A PL 387217A PL 38721709 A PL38721709 A PL 38721709A PL 387217 A1 PL387217 A1 PL 387217A1
Authority
PL
Poland
Prior art keywords
adenosine
borate derivatives
borate
derivatives
Prior art date
Application number
PL387217A
Other languages
Polish (pl)
Inventor
Zbigniew J. Leśnikowski
Agnieszka B. Olejniczak
Zofia Sulowska
Katarzyna Bednarska
Original Assignee
Instytut Biologii Medycznej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biologii Medycznej Polskiej Akademii Nauk filed Critical Instytut Biologii Medycznej Polskiej Akademii Nauk
Priority to PL387217A priority Critical patent/PL387217A1/en
Priority to PCT/PL2010/050004 priority patent/WO2010090541A1/en
Publication of PL387217A1 publication Critical patent/PL387217A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL387217A 2009-02-06 2009-02-06 Borate derivatives of adenosine PL387217A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL387217A PL387217A1 (en) 2009-02-06 2009-02-06 Borate derivatives of adenosine
PCT/PL2010/050004 WO2010090541A1 (en) 2009-02-06 2010-02-05 Borane derivates of adenosine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL387217A PL387217A1 (en) 2009-02-06 2009-02-06 Borate derivatives of adenosine

Publications (1)

Publication Number Publication Date
PL387217A1 true PL387217A1 (en) 2010-08-16

Family

ID=42124263

Family Applications (1)

Application Number Title Priority Date Filing Date
PL387217A PL387217A1 (en) 2009-02-06 2009-02-06 Borate derivatives of adenosine

Country Status (2)

Country Link
PL (1) PL387217A1 (en)
WO (1) WO2010090541A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016020858A2 (en) * 2014-08-05 2016-02-11 Instytut Biologii Medycznej Polskiej Akademii Nauk A nucleoside derivative for use as a drug, particularly for the treatment of chronic lymphocytic leukemia
CN106832242B (en) * 2017-01-17 2018-09-14 哈尔滨工业大学无锡新材料研究院 A kind of polyester synthesis catalyst and preparation method thereof
JP7161760B2 (en) * 2017-02-03 2022-10-27 国立大学法人東北大学 heterocyclic compound
CN109503671B (en) * 2019-01-03 2020-12-25 曲阜师范大学 Zwitterionic semi-sandwich iridium complex and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599796A (en) 1993-12-02 1997-02-04 Emory University Treatment of urogenital cancer with boron neutron capture therapy
US6180766B1 (en) 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
JP4618894B2 (en) 1999-01-22 2011-01-26 有限会社ケムフィズ Dicarba-clozo-dodecaborane derivatives
EP1364954A4 (en) 2001-02-09 2009-10-28 Hiroyuki Kagechika Dicarba-closo-dodecarborane derivatives

Also Published As

Publication number Publication date
WO2010090541A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
HK1173142A1 (en) N1-sulfonyl-5-fluoropyrimidinone derivatives n1--5-
HK1172893A1 (en) 5-fluoropyrimidinone derivatives 5-
ZA201203205B (en) Benzimidazole-imidazole derivatives
IL210855A (en) Adenine derivatives
IL216007A0 (en) Isoxazole-pyridine derivatives
EP2486039A4 (en) Purine derivatives useful as hsp90 inhibitors
ZA201106855B (en) Oxasiazole derivatives
IL215109A0 (en) Isoxazole-pyridazine derivatives
IL214941A0 (en) Isoxazole-pyrazole derivatives
ZA201104991B (en) Deoxyactagardine derivatives
HK1172894A1 (en) N1-acyl-5-fluoropyrimidinone derivatives n1--5-
HK1169623A1 (en) Pyrazinooxazepine derivatives
GB0817926D0 (en) Articles of clothiing
PL387217A1 (en) Borate derivatives of adenosine
EP2512482A4 (en) 2-aldoximino-5-fluoropyrimidine derivatives
ZA201104279B (en) Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives
GB0821710D0 (en) Derivatives of dihydroindolone
GB201003234D0 (en) Saccharide derivatives

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)